Stem cells are special kinds of cells in our body that can become any other type of cell. They have huge potential for medicine, and trials are currently under way using stem cells to replace damaged cells in diseases like Parkinson's.
can be reprogrammed into iPS cells in the lab. These"blank slate" cells show great promise in regenerative medicine, a field focused on regrowing, repairing or replacing damaged or diseased cells, organs or tissues.
Research using iPS cells is a rapidly advancing field, yet many technical challenges remain. Scientists are still figuring out how to better control whatOne of these technical challenges is"epigenetic memory", where the iPS cells retain traces of the cell type they once were.To understand"epigenetic memory", let's first talk about epigenetics. Our DNA carries sequences of instructions known as genes.
An iPS cell made from a skin cell can retain a partial"memory" of being a skin cell, which makes it more likely to turn back into a skin-like cell and less likely to turn into other cell types. This is because some of the DNA's epigenetic marks can tell the cell to behave like a skin cell.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
We will be watching Sir Michael Parkinson for years, says Gloria HunnifordHunniford said that the late broadcaster’s interviewing technique was ‘the best’.
Lire la suite »
We will be watching Sir Michael Parkinson for years, says Gloria HunnifordHunniford said that the late broadcaster’s interviewing technique was ‘the best’.
Lire la suite »
Cell therapy that repairs cornea damage with patient's own stem cells achieves positive phase I trial resultsA team led by researchers from Mass Eye and Ear, a member of Mass General Brigham, reports the results of a phase I trial of a revolutionary stem cell treatment called cultivated autologous limbal epithelial cell transplantation (CALEC), which was found to be safe and well-tolerated over the short term in four patients with significant chemical burns in one eye.
Lire la suite »